Altus Pharmaceuticals Inc. Appoints Bruce A. Leicher General Counsel

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, today announced that Bruce A. Leicher, J.D., joined the Company to serve as Sr. Vice President, General Counsel and Secretary. In this role, Mr. Leicher will provide legal advice to the Company on matters such as corporate governance and compliance, regulatory matters, business development, intellectual property, and general corporate matters. He has over 15 years’ experience in providing counsel in the life sciences industry.
MORE ON THIS TOPIC